Clinical Trials
2 trialsNCT01967758 2018-08-17
Phase I Study of Safety and Immunogenicity of ADU-623
Providence Health & Services
Phase 1 Completed
NCT00004216 2013-07-18
VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
National Cancer Institute (NCI)
Phase 1 Completed